These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 10620731

  • 21. Carbonic anhydrase inhibitors: topical sulfonamide antiglaucoma agents incorporating secondary amine moieties.
    Renzi G, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2000 Apr 03; 10(7):673-6. PubMed ID: 10762051
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Carbonic anhydrase inhibitors: novel compounds containing S-NH moieties: sulfenamido-sulfonamides, sulfenimido-sulfonamides and their interaction with isozymes I, II and IV.
    Scozzafava A, Supuran CT.
    J Enzyme Inhib; 1998 Sep 03; 13(6):419-42. PubMed ID: 9825306
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
    Mincione F, Starnotti M, Masini E, Bacciottini L, Scrivanti C, Casini A, Vullo D, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Sep 01; 15(17):3821-7. PubMed ID: 16039853
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3102-8. PubMed ID: 15905091
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cyclodextrin complexation highly enhances efficacy of arylsulfonylureido benzenesulfonamide carbonic anhydrase inhibitors as a topical antiglaucoma agents.
    Bragagni M, Bozdag M, Carta F, Scozzafava A, Lanzi C, Masini E, Mura P, Supuran CT.
    Bioorg Med Chem; 2015 Sep 15; 23(18):6223-7. PubMed ID: 26319622
    [Abstract] [Full Text] [Related]

  • 32. Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with N-hydroxysulfonamides--a novel class of intraocular pressure lowering agents.
    Mincione F, Menabuoni L, Briganti F, Mincione G, Scozzafava A, Supuran CT.
    J Enzyme Inhib; 1998 Jul 15; 13(4):267-84. PubMed ID: 9795865
    [Abstract] [Full Text] [Related]

  • 33. QSAR study on carbonic anhydrase inhibitors: water-soluble sulfonamides incorporating beta-alanyl moieties, possessing long lasting-intra ocular pressure lowering properties--a molecular connectivity approach.
    Agrawal VK, Banerji M, Gupta M, Singh J, Khadikar PV, Supuran CT.
    Eur J Med Chem; 2005 Oct 15; 40(10):1002-12. PubMed ID: 15961191
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents.
    Agrawal VK, Bano S, Supuran CT, Khadikar PV.
    Eur J Med Chem; 2004 Jul 15; 39(7):593-600. PubMed ID: 15236839
    [Abstract] [Full Text] [Related]

  • 36. Thieno[2,3-b]furan-2-sulfonamides as topical carbonic anhydrase inhibitors.
    Hartman GD, Halczenko W, Prugh JD, Smith RL, Sugrue MF, Mallorga P, Michelson SR, Randall WC, Schwam H, Sondey JM.
    J Med Chem; 1992 Aug 07; 35(16):3027-33. PubMed ID: 1501230
    [Abstract] [Full Text] [Related]

  • 37. Topically active ocular carbonic anhydrase inhibitors: novel biscarbonylamidothiadiazole sulfonamides as ocular hypotensive agents.
    Pierce WM, Sharir M, Waite KJ, Chen D, Kaysinger KK.
    Proc Soc Exp Biol Med; 1993 Jul 07; 203(3):360-5. PubMed ID: 8516347
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L, Fasolis G, Vullo D, Chohan ZH, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3096-101. PubMed ID: 15908204
    [Abstract] [Full Text] [Related]

  • 40. Synthesis and physicochemical properties of sulfamate derivatives as topical antiglaucoma agents.
    Lo YS, Nolan JC, Maren TH, Welstead WJ, Gripshover DF, Shamblee DA.
    J Med Chem; 1992 Dec 25; 35(26):4790-4. PubMed ID: 1479580
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.